Researchers analyzed results of an acute myocardial infarction trial that included patients from the United States, Canada, Australia, New Zealand and 13 European countries from 2004-2006. They found that the 30-day readmission rate for ST-segment elevation myocardial infarction patients was 14.5 percent in the United States compared to 9.9 percent in other countries.
Median length of stay was shortest in the United States at 3 days compared to 8 days in Germany. After adjusting for country-level median length of stay, U.S. location was no longer an independent predictor of 30-day readmission.
Related Articles on Hospital Cardiology:
Baptist Health Partners With Arkansas Cardiology in Heart Institute
CaroMont Health Acquires Mid Carolina Cardiology From Novant
Study: Proficiency May be Attained After 30 Transfemoral Aortic Valve Implantations
